Abaloparatide0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Abaloparatide — research data
Regulatory statusFDA-approved (Tymlos)
NCAA D1Not listed
Overview
About Abaloparatide
Mechanism of action
PTH-related protein analog; selective PTH1R agonist with preferential anabolic bone effects
Safety profile
Dizziness, nausea, palpitations, osteosarcoma risk (boxed warning) · Approved for osteoporosis; dizziness, nausea, injection site reactions; 2-year limit due to animal osteosarcoma data
Related pages